Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis.

Intensive care medicine experimental·2026
Same author

Civilian Occupational Exposure to Vapors, Gas, Dust, or Fumes and Respiratory Health Among United States Military Veterans.

American journal of industrial medicine·2026
Same author

Ceragenin-Coated Endotracheal Tubes for the Reduction of Ventilator-Associated Pneumonia: A Prospective, Longitudinal, Crossover, Interrupted Time, Implementation Study (CEASE VAP Study).

Critical care explorations·2026
Same author

Feasibility of Calculating and Maintaining Near-Infrared Spectroscopy-Guided Personalized Mean Arterial Pressure Targets in Adults With Critical Illness: A Pilot Clinical Study.

Critical care explorations·2026
Same author

Prophylaxis for venous thromboembolism in traumatic brain injury: protocol for a randomised controlled trial.

BMJ open·2025
Same author

The authors reply.

Critical care medicine·2025
Same journal

Chronic Opioid use in Adult Survivors of Pediatric ICU Admissions in Nova Scotia: A Retrospective Cohort Study.

Journal of intensive care medicine·2026
Same journal

The Middle Ground: Midline Catheter use and Trainee Involvement in US Critical Care Fellowships.

Journal of intensive care medicine·2026
Same journal

Effect of Acetylsalicylic Acid on Mortality in Sepsis: A Systematic Review and Meta-Analysis.

Journal of intensive care medicine·2026
Same journal

Arterial Blood Gas-Derived Risk Models for 28-Day Mortality in Critically Ill Adults: A Retrospective Cohort Study.

Journal of intensive care medicine·2026
Same journal

Ethical Considerations and End-of-Life Care in Donor and Transplant Critical Care.

Journal of intensive care medicine·2026
Same journal

To the Editor: Severe Necrotizing Lung Infections: Definitions and Therapeutic Indications.

Journal of intensive care medicine·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

In vitro Cell Culture Model for Toxic Inhaled Chemical Testing
05:44

In vitro Cell Culture Model for Toxic Inhaled Chemical Testing

Published on: May 8, 2014

Toxic inhalational exposures.

Tze-Ming Benson Chen1, Harjoth Malli, David M Maslove

  • 1Division of Pulmonary and Critical Care Medicine, California Pacific Medical Center, San Francisco, CA, USA.

Journal of Intensive Care Medicine
|January 11, 2012
PubMed
Summary
This summary is machine-generated.

Respirable toxicants, including gases and particles, cause lung injury and systemic disease via inhalation. Prompt medical care, including airway management and specific therapies, is crucial for survival.

Keywords:
acute lung injuryintensive care unitrespiratory failuresmoke inhalationtoxic gas

More Related Videos

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles
05:07

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles

Published on: March 18, 2019

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface
07:05

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Published on: June 20, 2025

Related Experiment Videos

Last Updated: May 26, 2026

In vitro Cell Culture Model for Toxic Inhaled Chemical Testing
05:44

In vitro Cell Culture Model for Toxic Inhaled Chemical Testing

Published on: May 8, 2014

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles
05:07

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles

Published on: March 18, 2019

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface
07:05

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Published on: June 20, 2025

Area of Science:

  • Toxicology
  • Environmental Health
  • Emergency Medicine

Background:

  • Respirable toxicants encompass irritant and non-irritant gases, vapors, fumes, and particles.
  • Inhalation exposure can lead to pulmonary injury and systemic diseases.
  • Sources include fires, industrial accidents, and intentional releases.

Purpose of the Study:

  • To review the nature of respirable toxicants.
  • To discuss the sources and health impacts of acute toxic inhalational exposures.
  • To outline the management strategies for affected individuals.

Main Methods:

  • Review of existing literature on toxic inhalational exposures.
  • Analysis of sources and mechanisms of injury.
  • Examination of current and potential treatment modalities.

Main Results:

  • Acute toxic inhalational exposures can cause respiratory failure, multisystem organ dysfunction, and death.
  • Effective management requires airway assessment, systemic toxicity monitoring, and targeted therapies.
  • Treatment options include antidotes, hyperbaric oxygen, and supportive care.

Conclusions:

  • Prompt recognition and management of acute toxic inhalational exposures are critical.
  • A multi-faceted approach involving airway protection, systemic support, and specific treatments improves patient outcomes.
  • Further research into novel therapies may enhance survival rates for severe exposures.